October 5 | 8 a.m. PT / 11 a.m. ET
Biopharma tech strategies in an era defined by data and AI
The scientific landscape has changed dramatically over the last ten years. Scientists have to contend with large, complex data sets, compressed timelines, and increased adoption of smart technologies. These days, it's not uncommon for scientists to use more than 20 applications to do their work and for IT teams to support 100+ lab instruments. And FAIR data still feels out of reach. Biopharma companies that can implement a strong tech and digital strategy that creates connections, collaboration, and tames chaos, will be ahead of the curve in a new era defined by artificial intelligence and more complex datasets.
About this webinar:
Malay Gandhi, Head of Strategy at Benchling, will discuss hurdles that biopharma needs to overcome to deploy a solid tech strategy as well as the key technologies that companies are investing in.
The discussion will be grounded by evidence and insights from the recent Biopharma Technology Benchmark Report, a survey of 300 global biopharma R&D and IT executives.
Register now
You're registered
Thank you for registering. We'll email you a calendar invite along with the details.
